MARKET

NWBO

NWBO

Northwest Bio
OTCMQB
0.172
+0.003
+1.72%
Closed 15:59 07/24 EDT
OPEN
0.174
PREV CLOSE
0.169
HIGH
0.174
LOW
0.169
VOLUME
657.70K
TURNOVER
112.42K
52 WEEK HIGH
0.368
52 WEEK LOW
0.142
MARKET CAP
282.49M
P/E (TTM)
-5.6176
1D
5D
1M
3M
1Y
5Y
1D
Northwest Biotherapeutics says UK regulator has not rejected DCVax-L glioblastoma filing
PUBT · 4d ago
Weekly Report: what happened at NWBO last week (0713-0717)?
Weekly Report · 4d ago
First Berlin reiterates Buy on Northwest Biotherapeutics, keeps USD 1 price target
PUBT · 07/13 13:22
Weekly Report: what happened at NWBO last week (0706-0710)?
Weekly Report · 07/13 09:40
Northwest Biotherapeutics's Newest Presentation Does Not De-Risk The Thesis, But The Story Is Not Over Yet
Seeking Alpha · 07/08 21:30
Northwest Bio says updated IPD analyses show DCVax-L extends glioblastoma survival more than prior Phase III readout
PUBT · 07/08 18:25
NORTHWEST BIOTHERAPEUTICS PRESENTS UPDATED SURVIVAL DATA FROM PHASE III TRIAL OF DCVAX®-L FOR GLIOBLASTOMA USING INDIVIDUAL PATIENT LEVEL DATA IN MULTIPLE INDEPENDENT ANALYSES
Reuters · 07/08 18:24
Weekly Report: what happened at NWBO last week (0629-0703)?
Weekly Report · 07/06 09:42
More
About NWBO
Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and includes treatment of a diverse range of more than a dozen types of cancers. Its subsidiaries include Flaskworks LLC, NW Bio GmbH, Northwest Biotherapeutics Capital Limited, Northwest Biotherapeutics B.V., Advent BioServices Ltd., and others.

Webull offers Northwest Biotherapeutics Inc stock information, including OTCMQB: NWBO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NWBO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NWBO stock methods without spending real money on the virtual paper trading platform.